{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:20:41Z","timestamp":1794360041871,"version":"4.9.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10555-025-10251-9","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:14:57Z","timestamp":1739902497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Mitochondrial alterations and signatures in hepatocellular carcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Tsung-Hsien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Feng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Kuang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"12","key":"10251_CR1","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/jnci\/djab131","volume":"113","author":"F Islami","year":"2021","unstructured":"Islami, F., Ward, E. M., Sung, H., Cronin, K. A., Tangka, F. K. L., Sherman, R. L., et al. (2021). Annual report to the nation on the status of cancer, part 1: National cancer statistics. Journal of the National Cancer Institute, 113(12), 1648\u20131669. https:\/\/doi.org\/10.1093\/jnci\/djab131","journal-title":"Journal of the National Cancer Institute"},{"issue":"24","key":"10251_CR2","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1002\/cncr.34479","volume":"128","author":"KA Cronin","year":"2022","unstructured":"Cronin, K. A., Scott, S., Firth, A. U., Sung, H., Henley, S. J., Sherman, R. L., et al. (2022). Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer, 128(24), 4251\u20134284. https:\/\/doi.org\/10.1002\/cncr.34479","journal-title":"Cancer"},{"issue":"15","key":"10251_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. (2019). Hepatocellular carcinoma. New England Journal of Medicine, 380(15), 1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10251_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7","key":"10251_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41575-019-0134-x","volume":"16","author":"S Ben-Moshe","year":"2019","unstructured":"Ben-Moshe, S., & Itzkovitz, S. (2019). Spatial heterogeneity in the mammalian liver. Nature Reviews. Gastroenterology & Hepatology, 16(7), 395\u2013410. https:\/\/doi.org\/10.1038\/s41575-019-0134-x","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10251_CR6","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.ceca.2020.102336","volume":"94","author":"B Morio","year":"2021","unstructured":"Morio, B., Panthu, B., Bassot, A., & Rieusset, J. (2021). Role of mitochondria in liver metabolic health and diseases. Cell Calcium, 94, 102336. https:\/\/doi.org\/10.1016\/j.ceca.2020.102336","journal-title":"Cell Calcium"},{"issue":"1","key":"10251_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-020-00539-4","volume":"18","author":"C Lu","year":"2020","unstructured":"Lu, C., Fang, S., Weng, Q., Lv, X., Meng, M., Zhu, J., et al. (2020). Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Communication and Signaling, 18(1), 97. https:\/\/doi.org\/10.1186\/s12964-020-00539-4","journal-title":"Cell Communication and Signaling"},{"issue":"5930","key":"10251_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 324(5930), 1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science"},{"issue":"1","key":"10251_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang, S., Long, H., Hou, L., Feng, B., Ma, Z., Wu, Y., et al. (2023). The mitophagy pathway and its implications in human diseases. Signal Transduction and Targeted Therapy, 8(1), 304. https:\/\/doi.org\/10.1038\/s41392-023-01503-7","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"3","key":"10251_CR10","doi-asserted-by":"publisher","first-page":"e0395","DOI":"10.1097\/HC9.0000000000000395","volume":"8","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z., Zhao, Q., Wang, Z., Xu, F., Liu, Y., Guo, Y., et al. (2024). Hepatocellular carcinoma cells downregulate NADH: Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis. Hepatology Communications, 8(3), e0395. https:\/\/doi.org\/10.1097\/HC9.0000000000000395","journal-title":"Hepatology Communications"},{"issue":"3","key":"10251_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10555-022-10071-1","volume":"42","author":"SQ Sin","year":"2023","unstructured":"Sin, S. Q., Mohan, C. D., Goh, R. M. W., You, M., Nayak, S. C., Chen, L., et al. (2023). Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities. Cancer Metastasis Reviews, 42(3), 741\u2013764. https:\/\/doi.org\/10.1007\/s10555-022-10071-1","journal-title":"Cancer Metastasis Reviews"},{"issue":"2","key":"10251_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41416-019-0658-4","volume":"122","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Li, T. E., Chen, M., Xu, D., Zhu, Y., Hu, B. Y., et al. (2020). MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming. British Journal of Cancer, 122(2), 209\u2013220. https:\/\/doi.org\/10.1038\/s41416-019-0658-4","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10251_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15698\/cst2020.06.221","volume":"4","author":"D Grasso","year":"2020","unstructured":"Grasso, D., Zampieri, L. X., Capeloa, T., Van de Velde, J. A., & Sonveaux, P. (2020). Mitochondria in cancer. Cell Stress, 4(6), 114\u2013146. https:\/\/doi.org\/10.15698\/cst2020.06.221","journal-title":"Cell Stress"},{"issue":"3","key":"10251_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023). Mitochondrial control of inflammation. Nature Reviews. Immunology, 23(3), 159\u2013173. https:\/\/doi.org\/10.1038\/s41577-022-00760-x","journal-title":"Nature Reviews. Immunology"},{"issue":"11","key":"10251_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrc.2016.85","volume":"16","author":"LB Sullivan","year":"2016","unstructured":"Sullivan, L. B., Gui, D. Y., & Vander Heiden, M. G. (2016). Altered metabolite levels in cancer: Implications for tumour biology and cancer therapy. Nature Reviews. Cancer, 16(11), 680\u2013693. https:\/\/doi.org\/10.1038\/nrc.2016.85","journal-title":"Nature Reviews. Cancer"},{"issue":"9","key":"10251_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","volume":"26","author":"HL Glover","year":"2024","unstructured":"Glover, H. L., Schreiner, A., Dewson, G., & Tait, S. W. G. (2024). Mitochondria and cell death. Nature Cell Biology, 26(9), 1434\u20131446. https:\/\/doi.org\/10.1038\/s41556-024-01429-4","journal-title":"Nature Cell Biology"},{"key":"10251_CR17","doi-asserted-by":"publisher","first-page":"102470","DOI":"10.1016\/j.redox.2022.102470","volume":"57","author":"S Hu","year":"2022","unstructured":"Hu, S., Feng, J., Wang, M., Wufuer, R., Liu, K., Zhang, Z., et al. (2022). Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks. Redox Biology, 57, 102470. https:\/\/doi.org\/10.1016\/j.redox.2022.102470","journal-title":"Redox Biology"},{"issue":"1","key":"10251_CR18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41467-024-45751-9","volume":"15","author":"SWS Kang","year":"2024","unstructured":"Kang, S. W. S., Cunningham, R. P., Miller, C. B., Brown, L. A., Cultraro, C. M., Harned, A., et al. (2024). A spatial map of hepatic mitochondria uncovers functional heterogeneity shaped by nutrient-sensing signaling. Nature Communications, 15(1), 1799. https:\/\/doi.org\/10.1038\/s41467-024-45751-9","journal-title":"Nature Communications"},{"issue":"2","key":"10251_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria, M. J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marin, J. J. G., et al. (2019). Wnt-beta-catenin signalling in liver development, health and disease. Nature Reviews. Gastroenterology & Hepatology, 16(2), 121\u2013136. https:\/\/doi.org\/10.1038\/s41575-018-0075-9","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10251_CR20","doi-asserted-by":"publisher","first-page":"806408","DOI":"10.3389\/fcell.2022.806408","volume":"10","author":"S Yu","year":"2022","unstructured":"Yu, S., Gao, J., Wang, H., Liu, L., Liu, X., Xu, Y., et al. (2022). Significance of Liver Zonation in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology, 10, 806408. https:\/\/doi.org\/10.3389\/fcell.2022.806408","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"10251_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tem.2023.10.002","volume":"35","author":"PMM Ruppert","year":"2024","unstructured":"Ruppert, P. M. M., & Kersten, S. (2024). Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting. Trends in Endocrinology and Metabolism, 35(2), 107\u2013124. https:\/\/doi.org\/10.1016\/j.tem.2023.10.002","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"10","key":"10251_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/cr.2016.109","volume":"26","author":"D Huang","year":"2016","unstructured":"Huang, D., Li, T., Wang, L., Zhang, L., Yan, R., Li, K., et al. (2016). Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Cell Research, 26(10), 1112\u20131130. https:\/\/doi.org\/10.1038\/cr.2016.109","journal-title":"Cell Research"},{"issue":"2","key":"10251_CR23","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms25021314","volume":"25","author":"TH Chen","year":"2024","unstructured":"Chen, T. H., Wang, H. C., Chang, C. J., & Lee, S. Y. (2024). Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation. International Journal of Molecular Sciences, 25(2), 1314. https:\/\/doi.org\/10.3390\/ijms25021314","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10251_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","volume":"94","author":"FM Yakes","year":"1997","unstructured":"Yakes, F. M., & Van Houten, B. (1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proceedings of the National Academy of Sciences of the United States of America, 94(2), 514\u2013519. https:\/\/doi.org\/10.1073\/pnas.94.2.514","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10251_CR25","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3390\/nu13114071","volume":"13","author":"YF Hsiao","year":"2021","unstructured":"Hsiao, Y. F., Cheng, S. B., Lai, C. Y., Liu, H. T., Huang, S. C., & Huang, Y. C. (2021). The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma. Nutrients, 13(11), 4071. https:\/\/doi.org\/10.3390\/nu13114071","journal-title":"Nutrients"},{"issue":"1","key":"10251_CR26","doi-asserted-by":"publisher","first-page":"e0170016","DOI":"10.1371\/journal.pone.0170016","volume":"12","author":"SB Cheng","year":"2017","unstructured":"Cheng, S. B., Liu, H. T., Chen, S. Y., Lin, P. T., Lai, C. Y., & Huang, Y. C. (2017). Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection. PLoS ONE, 12(1), e0170016. https:\/\/doi.org\/10.1371\/journal.pone.0170016","journal-title":"PLoS ONE"},{"issue":"8","key":"10251_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41556-019-0359-5","volume":"21","author":"L Sun","year":"2019","unstructured":"Sun, L., Wang, Y., Cen, J., Ma, X., Cui, L., Qiu, Z., et al. (2019). Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nature Cell Biology, 21(8), 1015\u20131026. https:\/\/doi.org\/10.1038\/s41556-019-0359-5","journal-title":"Nature Cell Biology"},{"key":"10251_CR28","doi-asserted-by":"publisher","first-page":"109699","DOI":"10.1016\/j.abb.2023.109699","volume":"744","author":"L Xing","year":"2023","unstructured":"Xing, L., Tang, Y., Li, L., & Tao, X. (2023). ROS in hepatocellular carcinoma: What we know. Archives of Biochemistry and Biophysics, 744, 109699. https:\/\/doi.org\/10.1016\/j.abb.2023.109699","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"9","key":"10251_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41580-022-00523-5","volume":"23","author":"L Heinke","year":"2022","unstructured":"Heinke, L. (2022). Mitochondrial ROS drive cell cycle progression. Nature Reviews. Molecular Cell Biology, 23(9), 581. https:\/\/doi.org\/10.1038\/s41580-022-00523-5","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1\u20133","key":"10251_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/s0014-5793(03)00338-7","volume":"542","author":"S Dong-Yun","year":"2003","unstructured":"Dong-Yun, S., Yu-Ru, D., Shan-Lin, L., Ya-Dong, Z., & Lian, W. (2003). Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation. FEBS Letters, 542(1\u20133), 60\u201364. https:\/\/doi.org\/10.1016\/s0014-5793(03)00338-7","journal-title":"FEBS Letters"},{"issue":"4","key":"10251_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41419-022-04806-9","volume":"13","author":"Q Wu","year":"2022","unstructured":"Wu, Q., Li, L., Miao, C., Hasnat, M., Sun, L., Jiang, Z., et al. (2022). Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2\/STAT3\/NOX1-mediated ROS production. Cell Death & Disease, 13(4), 341. https:\/\/doi.org\/10.1038\/s41419-022-04806-9","journal-title":"Cell Death & Disease"},{"issue":"12","key":"10251_CR32","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng, X., Qian, Y., Fu, B., Jiao, D., Jiang, Y., Chen, P., et al. (2019). Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nature Immunology, 20(12), 1656\u20131667. https:\/\/doi.org\/10.1038\/s41590-019-0511-1","journal-title":"Nature Immunology"},{"issue":"2","key":"10251_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-024-06536-6","volume":"15","author":"M Jing","year":"2024","unstructured":"Jing, M., Xiong, X., Mao, X., Song, Q., Zhang, L., Ouyang, Y., et al. (2024). HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia. Cell Death & Disease, 15(2), 155. https:\/\/doi.org\/10.1038\/s41419-024-06536-6","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10251_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/15384101.2024.2340864","volume":"23","author":"R Ma","year":"2024","unstructured":"Ma, R., Gao, Q. Y., Chen, Z. T., Liao, G. H., Li, S. T., Cai, J. W., et al. (2024). SIRT3 suppression resulting from the enhanced beta-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells. Cell Cycle, 23(4), 435\u2013447. https:\/\/doi.org\/10.1080\/15384101.2024.2340864","journal-title":"Cell Cycle"},{"key":"10251_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.redox.2017.08.013","volume":"14","author":"C Shi","year":"2018","unstructured":"Shi, C., Cai, Y., Li, Y., Li, Y., Hu, N., Ma, S., et al. (2018). Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin\/F-actin\/lamellipodium axis by regulation of JNK\/Bnip3\/SERCA\/CaMKII pathways. Redox Biology, 14, 59\u201371. https:\/\/doi.org\/10.1016\/j.redox.2017.08.013","journal-title":"Redox Biology"},{"key":"10251_CR36","doi-asserted-by":"publisher","first-page":"6917941","DOI":"10.1155\/2017\/6917941","volume":"2017","author":"ML Vignais","year":"2017","unstructured":"Vignais, M. L., Caicedo, A., Brondello, J. M., & Jorgensen, C. (2017). Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy. Stem Cells International, 2017, 6917941. https:\/\/doi.org\/10.1155\/2017\/6917941","journal-title":"Stem Cells International"},{"issue":"1","key":"10251_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13578-022-00747-0","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang, G., Fan, Y., Cao, P., & Tan, K. (2022). Insight into the mitochondrial unfolded protein response and cancer: Opportunities and challenges. Cell & Bioscience, 12(1), 18. https:\/\/doi.org\/10.1186\/s13578-022-00747-0","journal-title":"Cell & Bioscience"},{"key":"10251_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcell.2018.00031","volume":"6","author":"S Callegari","year":"2018","unstructured":"Callegari, S., & Dennerlein, S. (2018). Sensing the Stress: A Role for the UPR(mt) and UPR(am) in the Quality Control of Mitochondria. Frontiers in Cell and Developmental Biology, 6, 31. https:\/\/doi.org\/10.3389\/fcell.2018.00031","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"8","key":"10251_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.trecan.2020.04.009","volume":"6","author":"J O'Malley","year":"2020","unstructured":"O\u2019Malley, J., Kumar, R., Inigo, J., Yadava, N., & Chandra, D. (2020). Mitochondrial Stress Response and Cancer. Trends in Cancer, 6(8), 688\u2013701. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.009","journal-title":"Trends in Cancer"},{"issue":"3","key":"10251_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/cr.2018.16","volume":"28","author":"A Melber","year":"2018","unstructured":"Melber, A., & Haynes, C. M. (2018). UPR(mt) regulation and output: A stress response mediated by mitochondrial-nuclear communication. Cell Research, 28(3), 281\u2013295. https:\/\/doi.org\/10.1038\/cr.2018.16","journal-title":"Cell Research"},{"issue":"1","key":"10251_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41580-020-00300-2","volume":"22","author":"J Song","year":"2021","unstructured":"Song, J., Herrmann, J. M., & Becker, T. (2021). Quality control of the mitochondrial proteome. Nature Reviews. Molecular Cell Biology, 22(1), 54\u201370. https:\/\/doi.org\/10.1038\/s41580-020-00300-2","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"10","key":"10251_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41419-020-03062-z","volume":"11","author":"K Nouri","year":"2020","unstructured":"Nouri, K., Feng, Y., & Schimmer, A. D. (2020). Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy. Cell Death & Disease, 11(10), 841. https:\/\/doi.org\/10.1038\/s41419-020-03062-z","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10251_CR43","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh, S. P., Madke, T., & Chand, P. (2025). Global Epidemiology of Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology, 15(2), 102446. https:\/\/doi.org\/10.1016\/j.jceh.2024.102446","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"2","key":"10251_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI64265","volume":"123","author":"X Xu","year":"2013","unstructured":"Xu, X., Fan, Z., Kang, L., Han, J., Jiang, C., Zheng, X., et al. (2013). Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. Journal of Clinical Investigation, 123(2), 630\u2013645. https:\/\/doi.org\/10.1172\/JCI64265","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10251_CR45","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00705-005-0521-1","volume":"150","author":"SM Zhang","year":"2005","unstructured":"Zhang, S. M., Sun, D. C., Lou, S., Bo, X. C., Lu, Z., Qian, X. H., et al. (2005). HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70. Archives of Virology, 150(8), 1579\u20131590. https:\/\/doi.org\/10.1007\/s00705-005-0521-1","journal-title":"Archives of Virology"},{"issue":"7","key":"10251_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/iub.68","volume":"60","author":"HJ Kim","year":"2008","unstructured":"Kim, H. J., Kim, S. Y., Kim, J., Lee, H., Choi, M., Kim, J. K., et al. (2008). Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life, 60(7), 473\u2013480. https:\/\/doi.org\/10.1002\/iub.68","journal-title":"IUBMB Life"},{"issue":"1","key":"10251_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yexcr.2018.04.016","volume":"368","author":"XY Huang","year":"2018","unstructured":"Huang, X. Y., Li, D., Chen, Z. X., Huang, Y. H., Gao, W. Y., Zheng, B. Y., et al. (2018). Hepatitis B Virus X protein elevates Parkin-mediated mitophagy through Lon Peptidase in starvation. Experimental Cell Research, 368(1), 75\u201383. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.016","journal-title":"Experimental Cell Research"},{"issue":"5","key":"10251_CR48","doi-asserted-by":"publisher","first-page":"e0042424","DOI":"10.1128\/jvi.00424-24","volume":"98","author":"A Schollmeier","year":"2024","unstructured":"Schollmeier, A., Basic, M., Glitscher, M., & Hildt, E. (2024). The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype. Journal of Virology, 98(5), e0042424. https:\/\/doi.org\/10.1128\/jvi.00424-24","journal-title":"Journal of Virology"},{"issue":"3","key":"10251_CR49","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jcb.29471","volume":"121","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Liu, P., & Zhang, C. (2020). Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. Journal of Cellular Biochemistry, 121(3), 2489\u20132499. https:\/\/doi.org\/10.1002\/jcb.29471","journal-title":"Journal of Cellular Biochemistry"},{"issue":"12","key":"10251_CR50","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41419-019-2175-z","volume":"10","author":"YS Yoo","year":"2019","unstructured":"Yoo, Y. S., Park, Y. J., Lee, H. S., Oanh, N. T. K., Cho, M. Y., Heo, J., et al. (2019). Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis. Cell Death & Disease, 10(12), 938. https:\/\/doi.org\/10.1038\/s41419-019-2175-z","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10251_CR51","doi-asserted-by":"publisher","first-page":"e2854","DOI":"10.1002\/btpr.2854","volume":"35","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto, S., Safitri, A. R., Danoy, M., Maekawa, T., Kinoshita, H., Shinohara, M., et al. (2019). Investigation of the hepatic respiration and liver zonation on rat hepatocytes using an integrated oxygen biosensor in a microscale device. Biotechnology Progress, 35(5), e2854. https:\/\/doi.org\/10.1002\/btpr.2854","journal-title":"Biotechnology Progress"},{"issue":"5","key":"10251_CR52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Journal of Clinical Investigation, 115(5), 1343\u20131351. https:\/\/doi.org\/10.1172\/JCI23621","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10251_CR53","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi, D. F., Wang, C., Ho, C., Ladu, S., Lee, S. A., Mattu, S., et al. (2011). Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology, 140(3), 1071\u20131083. https:\/\/doi.org\/10.1053\/j.gastro.2010.12.006","journal-title":"Gastroenterology"},{"issue":"11","key":"10251_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F Rohrig","year":"2016","unstructured":"Rohrig, F., & Schulze, A. (2016). The multifaceted roles of fatty acid synthesis in cancer. Nature Reviews. Cancer, 16(11), 732\u2013749. https:\/\/doi.org\/10.1038\/nrc.2016.89","journal-title":"Nature Reviews. Cancer"},{"issue":"15","key":"10251_CR55","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/bph.15083","volume":"177","author":"X Li","year":"2020","unstructured":"Li, X., Shi, Z., Zhu, Y., Shen, T., Wang, H., Shui, G., et al. (2020). Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. British Journal of Pharmacology, 177(15), 3591\u20133607. https:\/\/doi.org\/10.1111\/bph.15083","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10251_CR56","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hep.28415","volume":"63","author":"MD Wang","year":"2016","unstructured":"Wang, M. D., Wu, H., Fu, G. B., Zhang, H. L., Zhou, X., Tang, L., et al. (2016). Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients. Hepatology, 63(4), 1272\u20131286. https:\/\/doi.org\/10.1002\/hep.28415","journal-title":"Hepatology"},{"issue":"2","key":"10251_CR57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jhep.2015.10.004","volume":"64","author":"L Li","year":"2016","unstructured":"Li, L., Pilo, G. M., Li, X., Cigliano, A., Latte, G., Che, L., et al. (2016). Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans. Journal of Hepatology, 64(2), 333\u2013341. https:\/\/doi.org\/10.1016\/j.jhep.2015.10.004","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10251_CR58","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","volume":"144","author":"A Budhu","year":"2013","unstructured":"Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., et al. (2013). Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology, 144(5), 1066\u20131075. https:\/\/doi.org\/10.1053\/j.gastro.2013.01.054","journal-title":"Gastroenterology"},{"issue":"1","key":"10251_CR59","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Z Ning","year":"2022","unstructured":"Ning, Z., Guo, X., Liu, X., Lu, C., Wang, A., Wang, X., et al. (2022). USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma. Nature communications, 13(1), 2187. https:\/\/doi.org\/10.1038\/s41467-022-29846-9","journal-title":"Nature communications"},{"issue":"3","key":"10251_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.livres.2018.09.005","volume":"2","author":"JJ Lemasters","year":"2018","unstructured":"Lemasters, J. J., & Zhong, Z. (2018). Mitophagy in hepatocytes: Types, initiators and role in adaptive ethanol metabolism\u2606. Liver Research, 2(3), 125\u2013132. https:\/\/doi.org\/10.1016\/j.livres.2018.09.005","journal-title":"Liver Research"},{"issue":"2","key":"10251_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/cells11020288","volume":"11","author":"J Massart","year":"2022","unstructured":"Massart, J., Begriche, K., Hartman, J. H., & Fromenty, B. (2022). Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver. Cells, 11(2), 288. https:\/\/doi.org\/10.3390\/cells11020288","journal-title":"Cells"},{"issue":"6","key":"10251_CR62","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jhep.2021.01.028","volume":"74","author":"L Conde de la Rosa","year":"2021","unstructured":"Conde de la Rosa, L., Garcia-Ruiz, C., Vallejo, C., Baulies, A., Nunez, S., Monte, M. J., et al. (2021). STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. Journal of Hepatology, 74(6), 1429\u20131441. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.028","journal-title":"Journal of Hepatology"},{"key":"10251_CR63","doi-asserted-by":"publisher","first-page":"6485871","DOI":"10.1155\/2021\/6485871","volume":"2021","author":"JH Xu","year":"2021","unstructured":"Xu, J. H., Guan, Y. J., Qiu, Z. D., Zhang, X., Zi, L. L., Zhou, Y., et al. (2021). System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity, 2021, 6485871. https:\/\/doi.org\/10.1155\/2021\/6485871","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"3","key":"10251_CR64","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41418-020-00657-z","volume":"28","author":"H Xian","year":"2021","unstructured":"Xian, H., & Liou, Y. C. (2021). Functions of outer mitochondrial membrane proteins: Mediating the crosstalk between mitochondrial dynamics and mitophagy. Cell Death & Differentiation, 28(3), 827\u2013842. https:\/\/doi.org\/10.1038\/s41418-020-00657-z","journal-title":"Cell Death & Differentiation"},{"issue":"1","key":"10251_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen, W., Zhao, H., & Li, Y. (2023). Mitochondrial dynamics in health and disease: Mechanisms and potential targets. Signal Transduction and Targeted Therapy, 8(1), 333. https:\/\/doi.org\/10.1038\/s41392-023-01547-9","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"29","key":"10251_CR66","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1073\/pnas.0904875106","volume":"106","author":"K Mitra","year":"2009","unstructured":"Mitra, K., Wunder, C., Roysam, B., Lin, G., & Lippincott-Schwartz, J. (2009). A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proceedings of the National Academy of Sciences of the United States of America, 106(29), 11960\u201311965. https:\/\/doi.org\/10.1073\/pnas.0904875106","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10251_CR67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-018-0987-x","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Li, H., Chang, H., Du, L., Hai, J., Geng, X., et al. (2018). MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma. Cell Death & Disease, 9(10), 956. https:\/\/doi.org\/10.1038\/s41419-018-0987-x","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10251_CR68","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello, M., Pyakurel, A., Glytsou, C., & Scorrano, L. (2020). The cell biology of mitochondrial membrane dynamics. Nature Reviews. Molecular Cell Biology, 21(4), 204\u2013224. https:\/\/doi.org\/10.1038\/s41580-020-0210-7","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1","key":"10251_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/cells9010121","volume":"9","author":"M Li","year":"2020","unstructured":"Li, M., Wang, L., Wang, Y., Zhang, S., Zhou, G., Lieshout, R., et al. (2020). Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth. Cells, 9(1), 121. https:\/\/doi.org\/10.3390\/cells9010121","journal-title":"Cells"},{"key":"10251_CR70","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.2147\/OTT.S98322","volume":"9","author":"X Feng","year":"2016","unstructured":"Feng, X., Zhu, K., Liu, J., Chen, J., Tang, J., Liang, Y., et al. (2016). The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy. OncoTargets and Therapy, 9, 3213\u20133221. https:\/\/doi.org\/10.2147\/OTT.S98322","journal-title":"OncoTargets and Therapy"},{"issue":"1","key":"10251_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2014.12.025","volume":"358","author":"W Wang","year":"2015","unstructured":"Wang, W., Xie, Q., Zhou, X., Yao, J., Zhu, X., Huang, P., et al. (2015). Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Letters, 358(1), 47\u201358. https:\/\/doi.org\/10.1016\/j.canlet.2014.12.025","journal-title":"Cancer Letters"},{"issue":"17","key":"10251_CR72","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1073\/pnas.1321114111","volume":"111","author":"SJ Kim","year":"2014","unstructured":"Kim, S. J., Syed, G. H., Khan, M., Chiu, W. W., Sohail, M. A., Gish, R. G., et al. (2014). Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proceedings of the National Academy of Sciences of the United States of America, 111(17), 6413\u20136418. https:\/\/doi.org\/10.1073\/pnas.1321114111","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10251_CR73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan, D. C. (2020). Mitochondrial Dynamics and Its Involvement in Disease. Annual Review of Pathology, 15, 235\u2013259. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032711","journal-title":"Annual Review of Pathology"},{"key":"10251_CR74","doi-asserted-by":"publisher","first-page":"15754","DOI":"10.1038\/ncomms15754","volume":"8","author":"B Cho","year":"2017","unstructured":"Cho, B., Cho, H. M., Jo, Y., Kim, H. D., Song, M., Moon, C., et al. (2017). Constriction of the mitochondrial inner compartment is a priming event for mitochondrial division. Nature Communications, 8, 15754. https:\/\/doi.org\/10.1038\/ncomms15754","journal-title":"Nature Communications"},{"issue":"7710","key":"10251_CR75","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-018-0211-2","volume":"558","author":"R Kalia","year":"2018","unstructured":"Kalia, R., Wang, R. Y., Yusuf, A., Thomas, P. V., Agard, D. A., Shaw, J. M., et al. (2018). Structural basis of mitochondrial receptor binding and constriction by DRP1. Nature, 558(7710), 401\u2013405. https:\/\/doi.org\/10.1038\/s41586-018-0211-2","journal-title":"Nature"},{"issue":"40","key":"10251_CR76","doi-asserted-by":"publisher","first-page":"65001","DOI":"10.18632\/oncotarget.11339","volume":"7","author":"L Zhan","year":"2016","unstructured":"Zhan, L., Cao, H., Wang, G., Lyu, Y., Sun, X., An, J., et al. (2016). Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-kappaB pathways in hepatocellular carcinoma. Oncotarget, 7(40), 65001\u201365011. https:\/\/doi.org\/10.18632\/oncotarget.11339","journal-title":"Oncotarget"},{"issue":"25","key":"10251_CR77","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41388-019-0772-z","volume":"38","author":"D Bao","year":"2019","unstructured":"Bao, D., Zhao, J., Zhou, X., Yang, Q., Chen, Y., Zhu, J., et al. (2019). Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression. Oncogene, 38(25), 5007\u20135020. https:\/\/doi.org\/10.1038\/s41388-019-0772-z","journal-title":"Oncogene"},{"issue":"7","key":"10251_CR78","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/liv.13660","volume":"38","author":"X Sun","year":"2018","unstructured":"Sun, X., Cao, H., Zhan, L., Yin, C., Wang, G., Liang, P., et al. (2018). Mitochondrial fission promotes cell migration by Ca2+ \/CaMKII\/ERK\/FAK pathway in hepatocellular carcinoma. Liver international, 38(7), 1263\u20131272. https:\/\/doi.org\/10.1111\/liv.13660","journal-title":"Liver international"},{"issue":"6","key":"10251_CR79","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","volume":"12","author":"Q Huang","year":"2016","unstructured":"Huang, Q., Zhan, L., Cao, H., Li, J., Lyu, Y., Guo, X., et al. (2016). Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy, 12(6), 999\u20131014. https:\/\/doi.org\/10.1080\/15548627.2016.1166318","journal-title":"Autophagy"},{"issue":"8","key":"10251_CR80","doi-asserted-by":"publisher","first-page":"109565","DOI":"10.1016\/j.celrep.2021.109565","volume":"36","author":"M Valera-Alberni","year":"2021","unstructured":"Valera-Alberni, M., Joffraud, M., Miro-Blanch, J., Capellades, J., Junza, A., Dayon, L., et al. (2021). Crosstalk between Drp1 phosphorylation sites during mitochondrial remodeling and their impact on metabolic adaptation. Cell Reports, 36(8), 109565. https:\/\/doi.org\/10.1016\/j.celrep.2021.109565","journal-title":"Cell Reports"},{"issue":"34","key":"10251_CR81","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1038\/onc.2017.98","volume":"36","author":"J Li","year":"2017","unstructured":"Li, J., Huang, Q., Long, X., Guo, X., Sun, X., Jin, X., et al. (2017). Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress. Oncogene, 36(34), 4901\u20134912. https:\/\/doi.org\/10.1038\/onc.2017.98","journal-title":"Oncogene"},{"issue":"10","key":"10251_CR82","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41419-020-2584-z","volume":"11","author":"T Yi","year":"2020","unstructured":"Yi, T., Luo, H., Qin, F., Jiang, Q., He, S., Wang, T., et al. (2020). LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission. Cell Death & Disease, 11(10), 832. https:\/\/doi.org\/10.1038\/s41419-020-2584-z","journal-title":"Cell Death & Disease"},{"key":"10251_CR83","doi-asserted-by":"publisher","first-page":"104952","DOI":"10.1016\/j.tiv.2020.104952","volume":"68","author":"US Swapna Sasi","year":"2020","unstructured":"Swapna Sasi, U. S., Sindhu, G., & Raghu, K. G. (2020). Fructose-palmitate based high calorie induce steatosis in HepG2 cells via mitochondrial dysfunction: An in vitro approach. Toxicology in Vitro, 68, 104952. https:\/\/doi.org\/10.1016\/j.tiv.2020.104952","journal-title":"Toxicology in Vitro"},{"issue":"9","key":"10251_CR84","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/cdd.2015.86","volume":"22","author":"K Palikaras","year":"2015","unstructured":"Palikaras, K., Lionaki, E., & Tavernarakis, N. (2015). Balancing mitochondrial biogenesis and mitophagy to maintain energy metabolism homeostasis. Cell Death & Differentiation, 22(9), 1399\u20131401. https:\/\/doi.org\/10.1038\/cdd.2015.86","journal-title":"Cell Death & Differentiation"},{"issue":"2","key":"10251_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., et al. (2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. Journal of Cell Biology, 189(2), 211\u2013221. https:\/\/doi.org\/10.1083\/jcb.200910140","journal-title":"Journal of Cell Biology"},{"issue":"1","key":"10251_CR86","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D. F., Gautier, C. A., Shen, J., et al. (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biology, 8(1), e1000298. https:\/\/doi.org\/10.1371\/journal.pbio.1000298","journal-title":"PLoS Biology"},{"issue":"1","key":"10251_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi, G., & Schwarz, T. L. (2013). The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death & Differentiation, 20(1), 31\u201342. https:\/\/doi.org\/10.1038\/cdd.2012.81","journal-title":"Cell Death & Differentiation"},{"issue":"12","key":"10251_CR88","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1096\/fj.201600698R","volume":"30","author":"MB Schaaf","year":"2016","unstructured":"Schaaf, M. B., Keulers, T. G., Vooijs, M. A., & Rouschop, K. M. (2016). LC3\/GABARAP family proteins: Autophagy-(un)related functions. FASEB Journal, 30(12), 3961\u20133978. https:\/\/doi.org\/10.1096\/fj.201600698R","journal-title":"FASEB Journal"},{"issue":"7","key":"10251_CR89","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41419-024-06804-5","volume":"15","author":"M Yang","year":"2024","unstructured":"Yang, M., Wei, X., Yi, X., & Jiang, D. S. (2024). Mitophagy-related regulated cell death: Molecular mechanisms and disease implications. Cell Death & Disease, 15(7), 505. https:\/\/doi.org\/10.1038\/s41419-024-06804-5","journal-title":"Cell Death & Disease"},{"key":"10251_CR90","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mito.2017.10.009","volume":"41","author":"J Harris","year":"2018","unstructured":"Harris, J., Deen, N., Zamani, S., & Hasnat, M. A. (2018). Mitophagy and the release of inflammatory cytokines. Mitochondrion, 41, 2\u20138. https:\/\/doi.org\/10.1016\/j.mito.2017.10.009","journal-title":"Mitochondrion"},{"issue":"12","key":"10251_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003722","volume":"9","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J., Khan, M., Quan, J., Till, A., Subramani, S., & Siddiqui, A. (2013). Hepatitis B virus disrupts mitochondrial dynamics: Induces fission and mitophagy to attenuate apoptosis. PLoS Pathogens, 9(12), e1003722. https:\/\/doi.org\/10.1371\/journal.ppat.1003722","journal-title":"PLoS Pathogens"},{"key":"10251_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13027-018-0212-7","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang, X., Liu, Y., Sun, J., Gong, W., Sun, P., Kong, X., et al. (2018). Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma. Infectious Agents and Cancer, 13, 36. https:\/\/doi.org\/10.1186\/s13027-018-0212-7","journal-title":"Infectious Agents and Cancer"},{"issue":"37","key":"10251_CR93","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1038\/onc.2017.136","volume":"36","author":"HC Chi","year":"2017","unstructured":"Chi, H. C., Chen, S. L., Lin, S. L., Tsai, C. Y., Chuang, W. Y., Lin, Y. H., et al. (2017). Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover. Oncogene, 36(37), 5274\u20135284. https:\/\/doi.org\/10.1038\/onc.2017.136","journal-title":"Oncogene"},{"issue":"6","key":"10251_CR94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","volume":"99","author":"NP Zhang","year":"2019","unstructured":"Zhang, N. P., Liu, X. J., Xie, L., Shen, X. Z., & Wu, J. (2019). Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Laboratory Investigation, 99(6), 749\u2013763. https:\/\/doi.org\/10.1038\/s41374-018-0177-6","journal-title":"Laboratory Investigation"},{"issue":"7","key":"10251_CR95","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00018-022-04385-0","volume":"79","author":"J Cai","year":"2022","unstructured":"Cai, J., Huang, J., Yang, J., Chen, X., Zhang, H., Zhu, Y., et al. (2022). The protective effect of selenoprotein M on non-alcoholic fatty liver disease: The role of the AMPKalpha1-MFN2 pathway and Parkin mitophagy. Cellular and Molecular Life Sciences, 79(7), 354. https:\/\/doi.org\/10.1007\/s00018-022-04385-0","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10251_CR96","doi-asserted-by":"publisher","first-page":"101120","DOI":"10.1016\/j.redox.2019.101120","volume":"21","author":"T Zhou","year":"2019","unstructured":"Zhou, T., Chang, L., Luo, Y., Zhou, Y., & Zhang, J. (2019). Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biology, 21, 101120. https:\/\/doi.org\/10.1016\/j.redox.2019.101120","journal-title":"Redox Biology"},{"key":"10251_CR97","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","volume":"18","author":"R Li","year":"2018","unstructured":"Li, R., Xin, T., Li, D., Wang, C., Zhu, H., & Zhou, H. (2018). Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biology, 18, 229\u2013243. https:\/\/doi.org\/10.1016\/j.redox.2018.07.011","journal-title":"Redox Biology"},{"issue":"2","key":"10251_CR98","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/hep.30191","volume":"69","author":"W Li","year":"2019","unstructured":"Li, W., Li, Y., Siraj, S., Jin, H., Fan, Y., Yang, X., et al. (2019). FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice. Hepatology, 69(2), 604\u2013621. https:\/\/doi.org\/10.1002\/hep.30191","journal-title":"Hepatology"},{"issue":"1","key":"10251_CR99","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu, X., Cao, J., Wan, X., & Du, S. (2024). Programmed cell death in hepatocellular carcinoma: Mechanisms and therapeutic prospects. Cell Death Discovery, 10(1), 356. https:\/\/doi.org\/10.1038\/s41420-024-02116-x","journal-title":"Cell Death Discovery"},{"issue":"6","key":"10251_CR100","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","volume":"53","author":"J Seo","year":"2021","unstructured":"Seo, J., Nam, Y. W., Kim, S., Oh, D. B., & Song, J. (2021). Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators. Experimental & Molecular Medicine, 53(6), 1007\u20131017. https:\/\/doi.org\/10.1038\/s12276-021-00634-7","journal-title":"Experimental & Molecular Medicine"},{"issue":"10","key":"10251_CR101","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","volume":"54","author":"MJ Morgan","year":"2022","unstructured":"Morgan, M. J., & Kim, Y. S. (2022). Roles of RIPK3 in necroptosis, cell signaling, and disease. Experimental & Molecular Medicine, 54(10), 1695\u20131704. https:\/\/doi.org\/10.1038\/s12276-022-00868-z","journal-title":"Experimental & Molecular Medicine"},{"issue":"7725","key":"10251_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer, M., Heinzmann, F., D\u2019Artista, L., Harbig, J., Roux, P. F., Hoenicke, L., et al. (2018). Necroptosis microenvironment directs lineage commitment in liver cancer. Nature, 562(7725), 69\u201375. https:\/\/doi.org\/10.1038\/s41586-018-0519-y","journal-title":"Nature"},{"issue":"1","key":"10251_CR103","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12885-023-11168-8","volume":"23","author":"K Zhang","year":"2023","unstructured":"Zhang, K., Li, J., & Yuan, E. (2023). A necroptosis-related gene signature to predict prognosis and immune features in hepatocellular carcinoma. BMC Cancer, 23(1), 660. https:\/\/doi.org\/10.1186\/s12885-023-11168-8","journal-title":"BMC Cancer"},{"issue":"34","key":"10251_CR104","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.3748\/wjg.v17.i34.3899","volume":"17","author":"B Hernandez-Breijo","year":"2011","unstructured":"Hernandez-Breijo, B., Monserrat, J., Ramirez-Rubio, S., Cuevas, E. P., Vara, D., Diaz-Laviada, I., et al. (2011). Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World Journal of Gastroenterology, 17(34), 3899\u20133911. https:\/\/doi.org\/10.3748\/wjg.v17.i34.3899","journal-title":"World Journal of Gastroenterology"},{"issue":"14","key":"10251_CR105","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1158\/0008-5472.CAN-15-2637","volume":"76","author":"S Rizza","year":"2016","unstructured":"Rizza, S., Montagna, C., Cardaci, S., Maiani, E., Di Giacomo, G., Sanchez-Quiles, V., et al. (2016). S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase. Cancer Research, 76(14), 4170\u20134182. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2637","journal-title":"Cancer Research"},{"issue":"9","key":"10251_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., et al. (2022). Role of pyroptosis in inflammation and cancer. Cellular & Molecular Immunology, 19(9), 971\u2013992. https:\/\/doi.org\/10.1038\/s41423-022-00905-x","journal-title":"Cellular & Molecular Immunology"},{"issue":"1","key":"10251_CR107","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/41420-022-01101-6","volume":"8","author":"L Lu","year":"2022","unstructured":"Lu, L., Zhang, Y., Tan, X., Merkher, Y., Leonov, S., Zhu, L., et al. (2022). Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer. Cell Death Discovery, 8(1), 338. https:\/\/doi.org\/10.1038\/41420-022-01101-6","journal-title":"Cell Death Discovery"},{"key":"10251_CR108","doi-asserted-by":"publisher","first-page":"1371743","DOI":"10.3389\/fimmu.2024.1371743","volume":"15","author":"L Cigalotto","year":"2024","unstructured":"Cigalotto, L., & Martinvalet, D. (2024). Granzymes in health and diseases: The good, the bad and the ugly. Frontiers in Immunology, 15, 1371743. https:\/\/doi.org\/10.3389\/fimmu.2024.1371743","journal-title":"Frontiers in Immunology"},{"issue":"7799","key":"10251_CR109","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Zhang, Y., Xia, S., Kong, Q., Li, S., Liu, X., et al. (2020). Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature, 579(7799), 415\u2013420. https:\/\/doi.org\/10.1038\/s41586-020-2071-9","journal-title":"Nature"},{"issue":"51","key":"10251_CR110","doi-asserted-by":"publisher","first-page":"84658","DOI":"10.18632\/oncotarget.12384","volume":"7","author":"Q Chu","year":"2016","unstructured":"Chu, Q., Jiang, Y., Zhang, W., Xu, C., Du, W., Tuguzbaeva, G., et al. (2016). Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma. Oncotarget, 7(51), 84658\u201384665. https:\/\/doi.org\/10.18632\/oncotarget.12384","journal-title":"Oncotarget"},{"issue":"23","key":"10251_CR111","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.26355\/eurrev_201812_16511","volume":"22","author":"YF Chen","year":"2018","unstructured":"Chen, Y. F., Qi, H. Y., & Wu, F. L. (2018). Euxanthone exhibits anti-proliferative and anti-invasive activities in hepatocellular carcinoma by inducing pyroptosis: Preliminary results. European Review for Medical and Pharmacological Sciences, 22(23), 8186\u20138196. https:\/\/doi.org\/10.26355\/eurrev_201812_16511","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10251_CR112","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei, Q., Mu, K., Li, T., Zhang, Y., Yang, Z., Jia, X., et al. (2014). Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Laboratory Investigation, 94(1), 52\u201362. https:\/\/doi.org\/10.1038\/labinvest.2013.126","journal-title":"Laboratory Investigation"},{"issue":"1","key":"10251_CR113","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","volume":"10","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y., Yu, Y., Pan, Z., Glandorff, C., & Sun, M. (2024). Ferroptosis: A new hunter of hepatocellular carcinoma. Cell Death Discovery, 10(1), 136. https:\/\/doi.org\/10.1038\/s41420-024-01863-1","journal-title":"Cell Death Discovery"},{"issue":"8","key":"10251_CR114","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Lu, S., Wu, L. L., Yang, L., Yang, L., & Wang, J. (2023). The diversified role of mitochondria in ferroptosis in cancer. Cell Death & Disease, 14(8), 519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10251_CR115","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/cancers14051165","volume":"14","author":"X Luo","year":"2022","unstructured":"Luo, X., Ji, X., Xie, M., Zhang, T., Wang, Y., Sun, M., et al. (2022). Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy. Cancers (Basel), 14(5), 1165. https:\/\/doi.org\/10.3390\/cancers14051165","journal-title":"Cancers (Basel)"},{"key":"10251_CR116","doi-asserted-by":"publisher","first-page":"103002","DOI":"10.1016\/j.redox.2023.103002","volume":"69","author":"X Yang","year":"2024","unstructured":"Yang, X., Gu, C., Cai, J., Li, F., He, X., Luo, L., et al. (2024). Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis. Redox Biology, 69, 103002. https:\/\/doi.org\/10.1016\/j.redox.2023.103002","journal-title":"Redox Biology"},{"key":"10251_CR117","doi-asserted-by":"publisher","first-page":"117769","DOI":"10.1016\/j.biopha.2024.117769","volume":"182","author":"S Tu","year":"2025","unstructured":"Tu, S., Zou, Y., Yang, M., Zhou, X., Zheng, X., Jiang, Y., et al. (2025). Ferroptosis in hepatocellular carcinoma: Mechanisms and therapeutic implications. Biomedicine & Pharmacotherapy, 182, 117769. https:\/\/doi.org\/10.1016\/j.biopha.2024.117769","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"15","key":"10251_CR118","doi-asserted-by":"publisher","first-page":"e2206669","DOI":"10.1002\/advs.202206669","volume":"10","author":"D Zhang","year":"2023","unstructured":"Zhang, D., Man, D., Lu, J., Jiang, Y., Ding, B., Su, R., et al. (2023). Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science, 10(15), e2206669. https:\/\/doi.org\/10.1002\/advs.202206669","journal-title":"Advanced Science"},{"issue":"5","key":"10251_CR119","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang, D., Kroemer, G., & Kang, R. (2024). Targeting cuproplasia and cuproptosis in cancer. Nature Reviews. Clinical Oncology, 21(5), 370\u2013388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10251_CR120","doi-asserted-by":"publisher","first-page":"711227","DOI":"10.3389\/fmolb.2021.711227","volume":"8","author":"LM Ruiz","year":"2021","unstructured":"Ruiz, L. M., Libedinsky, A., & Elorza, A. A. (2021). Role of Copper on Mitochondrial Function and Metabolism. Frontiers in Molecular Biosciences, 8, 711227. https:\/\/doi.org\/10.3389\/fmolb.2021.711227","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"Pt 2","key":"10251_CR121","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.freeradbiomed.2022.11.023","volume":"193","author":"Y Yang","year":"2022","unstructured":"Yang, Y., Liang, S., Geng, H., Xiong, M., Li, M., Su, Q., et al. (2022). Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore. Free Radical Biology & Medicine, 193(Pt 2), 638\u2013647. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.023","journal-title":"Free Radical Biology & Medicine"},{"issue":"8","key":"10251_CR122","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023). Copper metabolism in cell death and autophagy. Autophagy, 19(8), 2175\u20132195. https:\/\/doi.org\/10.1080\/15548627.2023.2200554","journal-title":"Autophagy"},{"issue":"10","key":"10251_CR123","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.18632\/oncotarget.24282","volume":"9","author":"C Porcu","year":"2018","unstructured":"Porcu, C., Antonucci, L., Barbaro, B., Illi, B., Nasi, S., Martini, M., et al. (2018). Copper\/MYC\/CTR1 interplay: A dangerous relationship in hepatocellular carcinoma. Oncotarget, 9(10), 9325\u20139343. https:\/\/doi.org\/10.18632\/oncotarget.24282","journal-title":"Oncotarget"},{"issue":"3","key":"10251_CR124","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41416-024-02684-w","volume":"131","author":"K Chen","year":"2024","unstructured":"Chen, K., Shuen, T. W. H., & Chow, P. K. H. (2024). The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications. British Journal of Cancer, 131(3), 420\u2013429. https:\/\/doi.org\/10.1038\/s41416-024-02684-w","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10251_CR125","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/hep.31600","volume":"73","author":"HY Tan","year":"2021","unstructured":"Tan, H. Y., Wang, N., Zhang, C., Chan, Y. T., Yuen, M. F., & Feng, Y. (2021). Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis. Hepatology, 73(6), 2326\u20132341. https:\/\/doi.org\/10.1002\/hep.31600","journal-title":"Hepatology"},{"issue":"1","key":"10251_CR126","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-2007-967203","volume":"27","author":"R Xu","year":"2007","unstructured":"Xu, R., Bu-Ghanim, M., Fiel, M. I., Schiano, T., Cohen, E., & Thung, S. N. (2007). Hepatocellular carcinoma associated with an atypical presentation of Wilson\u2019s disease. Seminars in Liver Disease, 27(1), 122\u2013127. https:\/\/doi.org\/10.1055\/s-2007-967203","journal-title":"Seminars in Liver Disease"},{"issue":"4 Pt 1","key":"10251_CR127","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/jhep.2000.17705","volume":"32","author":"T Masaki","year":"2000","unstructured":"Masaki, T., Shiratori, Y., Rengifo, W., Igarashi, K., Matsumoto, K., Nishioka, M., et al. (2000). Hepatocellular carcinoma cell cycle: Study of Long-Evans cinnamon rats. Hepatology, 32(4 Pt 1), 711\u2013720. https:\/\/doi.org\/10.1053\/jhep.2000.17705","journal-title":"Hepatology"},{"issue":"1","key":"10251_CR128","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024). Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects. Signal Transduction and Targeted Therapy, 9(1), 271. https:\/\/doi.org\/10.1038\/s41392-024-01969-z","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10251_CR129","doi-asserted-by":"publisher","first-page":"1186659","DOI":"10.3389\/fonc.2023.1186659","volume":"13","author":"C Zhou","year":"2023","unstructured":"Zhou, C., Yang, J., Liu, T., Jia, R., Yang, L., Sun, P., et al. (2023). Copper metabolism and hepatocellular carcinoma: Current insights. Frontiers in Oncology, 13, 1186659. https:\/\/doi.org\/10.3389\/fonc.2023.1186659","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10251_CR130","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue, Q., Yan, D., Chen, X., Li, X., Kang, R., Klionsky, D. J., et al. (2023). Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy, 19(7), 1982\u20131996. https:\/\/doi.org\/10.1080\/15548627.2023.2165323","journal-title":"Autophagy"},{"key":"10251_CR131","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.redox.2021.102122","volume":"46","author":"X Ren","year":"2021","unstructured":"Ren, X., Li, Y., Zhou, Y., Hu, W., Yang, C., Jing, Q., et al. (2021). Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis. Redox Biology, 46, 102122. https:\/\/doi.org\/10.1016\/j.redox.2021.102122","journal-title":"Redox Biology"},{"issue":"12","key":"10251_CR132","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao, W., Huang, Z., Duan, J., Nice, E. C., Lin, J., & Huang, C. (2021). Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Molecular Oncology, 15(12), 3527\u20133544. https:\/\/doi.org\/10.1002\/1878-0261.13079","journal-title":"Molecular Oncology"},{"issue":"1","key":"10251_CR133","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2024","unstructured":"Qian, L., Zhu, Y., Deng, C., Liang, Z., Chen, J., Chen, Y., et al. (2024). Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduction and Targeted Therapy, 9(1), 50. https:\/\/doi.org\/10.1038\/s41392-024-01756-w","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"10251_CR134","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hep.31280","volume":"73","author":"Q Zuo","year":"2021","unstructured":"Zuo, Q., He, J., Zhang, S., Wang, H., Jin, G., Jin, H., et al. (2021). PPARgamma Coactivator-1alpha Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARgamma-Dependent WNT\/beta-Catenin\/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis. Hepatology, 73(2), 644\u2013660. https:\/\/doi.org\/10.1002\/hep.31280","journal-title":"Hepatology"},{"issue":"1","key":"10251_CR135","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1038\/s41467-023-41304-8","volume":"14","author":"SR Mihaylov","year":"2023","unstructured":"Mihaylov, S. R., Castelli, L. M., Lin, Y. H., Gul, A., Soni, N., Hastings, C., et al. (2023). The master energy homeostasis regulator PGC-1alpha exhibits an mRNA nuclear export function. Nature Communications, 14(1), 5496. https:\/\/doi.org\/10.1038\/s41467-023-41304-8","journal-title":"Nature Communications"},{"issue":"11","key":"10251_CR136","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/ijms19113447","volume":"19","author":"CF Cheng","year":"2018","unstructured":"Cheng, C. F., Ku, H. C., & Lin, H. (2018). PGC-1alpha as a Pivotal Factor in Lipid and Metabolic Regulation. International Journal of Molecular Sciences, 19(11), 3447. https:\/\/doi.org\/10.3390\/ijms19113447","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10251_CR137","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hep.29184","volume":"66","author":"S Tohme","year":"2017","unstructured":"Tohme, S., Yazdani, H. O., Liu, Y., Loughran, P., van der Windt, D. J., Huang, H., et al. (2017). Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction. Hepatology, 66(1), 182\u2013197. https:\/\/doi.org\/10.1002\/hep.29184","journal-title":"Hepatology"},{"issue":"1","key":"10251_CR138","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-023-00491-1","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo, S., Li, F., Liang, Y., Zheng, Y., Mo, Y., Zhao, D., et al. (2023). AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1\/PGC-1alpha signaling. Oncogenesis, 12(1), 46. https:\/\/doi.org\/10.1038\/s41389-023-00491-1","journal-title":"Oncogenesis"},{"issue":"1","key":"10251_CR139","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei, H. E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Pozzoli, G., et al. (2021). p53 signaling in cancer progression and therapy. Cancer cell international, 21(1), 703. https:\/\/doi.org\/10.1186\/s12935-021-02396-8","journal-title":"Cancer cell international"},{"issue":"1","key":"10251_CR140","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13062-023-00428-z","volume":"18","author":"R Liu","year":"2023","unstructured":"Liu, R., Yin, C., Zhao, P., Guo, B., Ke, W., Zheng, X., et al. (2023). Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1\/2-CREB axis. Biology direct, 18(1), 67. https:\/\/doi.org\/10.1186\/s13062-023-00428-z","journal-title":"Biology direct"},{"key":"10251_CR141","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2147\/IJGM.S351263","volume":"15","author":"M Atyah","year":"2022","unstructured":"Atyah, M., Zhou, C., Zhou, Q., Chen, W., Weng, J., Wang, P., et al. (2022). The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients. International Journal of General Medicine, 15, 737\u2013748. https:\/\/doi.org\/10.2147\/IJGM.S351263","journal-title":"International Journal of General Medicine"},{"key":"10251_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.713721","volume":"11","author":"J Bian","year":"2021","unstructured":"Bian, J., Zhang, D., Wang, Y., Qin, H., Yang, W., Cui, R., et al. (2021). Mitochondrial Quality Control in Hepatocellular Carcinoma. Frontiers in Oncology, 11, 713721. https:\/\/doi.org\/10.3389\/fonc.2021.713721","journal-title":"Frontiers in Oncology"},{"issue":"23","key":"10251_CR143","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/cells11233754","volume":"11","author":"N Kozhukhar","year":"2022","unstructured":"Kozhukhar, N., & Alexeyev, M. F. (2022). TFAM\u2019s Contributions to mtDNA Replication and OXPHOS Biogenesis Are Genetically Separable. Cells, 11(23), 3754. https:\/\/doi.org\/10.3390\/cells11233754","journal-title":"Cells"},{"issue":"2","key":"10251_CR144","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-023-00661-4","volume":"25","author":"BG Tan","year":"2024","unstructured":"Tan, B. G., Gustafsson, C. M., & Falkenberg, M. (2024). Mechanisms and regulation of human mitochondrial transcription. Nature Reviews. Molecular Cell Biology, 25(2), 119\u2013132. https:\/\/doi.org\/10.1038\/s41580-023-00661-4","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"11","key":"10251_CR145","doi-asserted-by":"publisher","first-page":"e110324","DOI":"10.15252\/embj.2021110324","volume":"41","author":"Q Huang","year":"2022","unstructured":"Huang, Q., Wu, D., Zhao, J., Yan, Z., Chen, L., Guo, S., et al. (2022). TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis. EMBO Journal, 41(11), e110324. https:\/\/doi.org\/10.15252\/embj.2021110324","journal-title":"EMBO Journal"},{"issue":"8","key":"10251_CR146","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cells10081901","volume":"10","author":"HY Lee","year":"2021","unstructured":"Lee, H. Y., Nga, H. T., Tian, J., & Yi, H. S. (2021). Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma. Cells, 10(8), 1901. https:\/\/doi.org\/10.3390\/cells10081901","journal-title":"Cells"},{"key":"10251_CR147","doi-asserted-by":"publisher","first-page":"111329","DOI":"10.1016\/j.cellsig.2024.111329","volume":"122","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Virmani, T., Kumar, G., Sharma, A., Virmani, R., Gugulothu, D., et al. (2024). Mitochondrial signaling pathways and their role in cancer drug resistance. Cellular signalling, 122, 111329. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111329","journal-title":"Cellular signalling"},{"issue":"1","key":"10251_CR148","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2017.01.021","volume":"483","author":"J Tan","year":"2017","unstructured":"Tan, J., Song, M., Zhou, M., & Hu, Y. (2017). Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage. Biochemical and Biophysical Research Communications, 483(1), 17\u201323. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.021","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10251_CR149","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/cancers12061663","volume":"12","author":"JJG Marin","year":"2020","unstructured":"Marin, J. J. G., Macias, R. I. R., Monte, M. J., Romero, M. R., Asensio, M., Sanchez-Martin, A., et al. (2020). Molecular Bases of Drug Resistance in Hepatocellular Carcinoma. Cancers (Basel), 12(6), 1633. https:\/\/doi.org\/10.3390\/cancers12061663","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10251_CR150","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/cancers12020332","volume":"12","author":"B Cucarull","year":"2020","unstructured":"Cucarull, B., Tutusaus, A., Subias, M., Stefanovic, M., Hernaez-Alsina, T., Boix, L., et al. (2020). Regorafenib Alteration of the BCL-xL\/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models. Cancers (Basel), 12(2), 332. https:\/\/doi.org\/10.3390\/cancers12020332","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10251_CR151","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.ymthe.2019.06.014","volume":"27","author":"JF Zheng","year":"2019","unstructured":"Zheng, J. F., He, S., Zeng, Z., Gu, X., Cai, L., & Qi, G. (2019). PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy. Molecular therapy, 27(10), 1784\u20131795. https:\/\/doi.org\/10.1016\/j.ymthe.2019.06.014","journal-title":"Molecular therapy"},{"issue":"8","key":"10251_CR152","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1158\/0008-5472.CAN-18-2110","volume":"79","author":"K Fekir","year":"2019","unstructured":"Fekir, K., Dubois-Pot-Schneider, H., Desert, R., Daniel, Y., Glaise, D., Rauch, C., et al. (2019). Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance. Cancer Research, 79(8), 1869\u20131883. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2110","journal-title":"Cancer Research"},{"key":"10251_CR153","doi-asserted-by":"publisher","first-page":"144807","DOI":"10.1016\/j.gene.2020.144807","volume":"753","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y., Xu, J., Hu, W., Wang, F., Zhou, Y., Xu, W., et al. (2020). TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction. Gene, 753, 144807. https:\/\/doi.org\/10.1016\/j.gene.2020.144807","journal-title":"Gene"},{"issue":"6","key":"10251_CR154","doi-asserted-by":"publisher","first-page":"119752","DOI":"10.1016\/j.bbamcr.2024.119752","volume":"1871","author":"K Deepak","year":"2024","unstructured":"Deepak, K., Roy, P. K., Das, C. K., Mukherjee, B., & Mandal, M. (2024). Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistance. Biochimica Et Biophysica. Acta Molecular Cell Research, 1871(6), 119752. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119752","journal-title":"Biochimica Et Biophysica. Acta Molecular Cell Research"},{"key":"10251_CR155","doi-asserted-by":"publisher","first-page":"113885","DOI":"10.1016\/j.bcp.2020.113885","volume":"176","author":"S Rizza","year":"2020","unstructured":"Rizza, S., Di Leo, L., Mandatori, S., De Zio, D., & Filomeni, G. (2020). Mitophagy contributes to alpha-tocopheryl succinate toxicity in GSNOR-deficient hepatocellular carcinoma. Biochemical Pharmacology, 176, 113885. https:\/\/doi.org\/10.1016\/j.bcp.2020.113885","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"10251_CR156","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/jpi.12358","volume":"61","author":"N Prieto-Dominguez","year":"2016","unstructured":"Prieto-Dominguez, N., Ordonez, R., Fernandez, A., Mendez-Blanco, C., Baulies, A., Garcia-Ruiz, C., et al. (2016). Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Journal of Pineal Research, 61(3), 396\u2013407. https:\/\/doi.org\/10.1111\/jpi.12358","journal-title":"Journal of Pineal Research"},{"issue":"4","key":"10251_CR157","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14728222.2020.1737013","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Su, G. F., Huang, Z. X., Wang, Z. G., Zhou, P. J., Fan, J. L., et al. (2020). Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC). Expert Opinion on Therapeutic Targets, 24(4), 389\u2013402. https:\/\/doi.org\/10.1080\/14728222.2020.1737013","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"3","key":"10251_CR158","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","volume":"44","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Li, X. M., Shi, X. H., Ye, K., Fu, X. L., Wang, X., et al. (2023). Sorafenib triggers ferroptosis via inhibition of HBXIP\/SCD axis in hepatocellular carcinoma. Acta Pharmacologica Sinica, 44(3), 622\u2013634. https:\/\/doi.org\/10.1038\/s41401-022-00981-9","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"10251_CR159","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","volume":"14","author":"M Zhan","year":"2023","unstructured":"Zhan, M., Ding, Y., Huang, S., Liu, Y., Xiao, J., Yu, H., et al. (2023). Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nature communications, 14(1), 3123. https:\/\/doi.org\/10.1038\/s41467-023-38753-6","journal-title":"Nature communications"},{"issue":"4","key":"10251_CR160","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/hep.30666","volume":"70","author":"C Hage","year":"2019","unstructured":"Hage, C., Hoves, S., Strauss, L., Bissinger, S., Prinz, Y., Poschinger, T., et al. (2019). Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma. Hepatology, 70(4), 1280\u20131297. https:\/\/doi.org\/10.1002\/hep.30666","journal-title":"Hepatology"},{"issue":"8","key":"10251_CR161","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.apsb.2020.06.015","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Zhang, P., An, L., Sun, N., Peng, L., Tang, W., et al. (2020). Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta pharmaceutica Sinica. B, 10(8), 1397\u20131413. https:\/\/doi.org\/10.1016\/j.apsb.2020.06.015","journal-title":"Acta pharmaceutica Sinica. B"},{"issue":"1","key":"10251_CR162","doi-asserted-by":"publisher","first-page":"249","DOI":"10.21873\/invivo.12253","volume":"35","author":"WF Liang","year":"2021","unstructured":"Liang, W. F., Gong, Y. X., Li, H. F., Sun, F. L., Li, W. L., Chen, D. Q., et al. (2021). Curcumin Activates ROS Signaling to Promote Pyroptosis in Hepatocellular Carcinoma HepG2 Cells. In Vivo, 35(1), 249\u2013257. https:\/\/doi.org\/10.21873\/invivo.12253","journal-title":"In Vivo"},{"issue":"5","key":"10251_CR163","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s43440-020-00064-8","volume":"72","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Yang, H., Sun, M., He, T., Liu, Y., Yang, X., et al. (2020). Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis. Pharmacological Reports, 72(5), 1370\u20131382. https:\/\/doi.org\/10.1007\/s43440-020-00064-8","journal-title":"Pharmacological Reports"},{"issue":"7","key":"10251_CR164","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3727\/096504018X15462920753012","volume":"27","author":"Q Wei","year":"2019","unstructured":"Wei, Q., Zhu, R., Zhu, J., Zhao, R., & Li, M. (2019). E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells. Oncology Research, 27(7), 827\u2013834. https:\/\/doi.org\/10.3727\/096504018X15462920753012","journal-title":"Oncology Research"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10251-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T03:03:03Z","timestamp":1743303783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10251-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10251"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10251-9","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}